Arrowhead Pharmaceuticals Inc (ARWR.PH) Quote| Reuters.com
Edition:
United States

Arrowhead Pharmaceuticals Inc (ARWR.PH)

ARWR.PH on Philadelphia Stock Exchange

5.51USD
1 Jul 2016
Change (% chg)

$0.20 (+3.77%)
Prev Close
$5.31
Open
$5.47
Day's High
$5.51
Day's Low
$5.47
Volume
653
Avg. Vol
3,098
52-wk High
$9.21
52-wk Low
$3.13

ARWR.PH

Chart for ARWR.PH

About

Arrowhead Pharmaceuticals, Inc., formerly Arrowhead Research Corporation, is a biopharmaceutical company. The Company is engaged in developing RiboNucleic Acid interference (RNAi) therapeutics. Its products include ARC-520, ARC-521, ARC-AAT, ARC-F12, ARC-HIF2 and ARC-LPA. ARC-520 is designed to treat chronic hepatitis B virus... (more)

Overall

Beta: 2.35
Market Cap(Mil.): $318.99
Shares Outstanding(Mil.): 59.96
Dividend: --
Yield (%): --

Financials

  ARWR.PH Industry Sector
P/E (TTM): -- 42.29 36.15
EPS (TTM): -1.36 -- --
ROI: -69.97 -6.23 14.31
ROE: -73.67 -5.61 15.51

BRIEF-Arrowhead Pharmaceuticals reports Q2 loss per share $0.35

* Q2 earnings per share view $-0.37 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

May 10 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : New Constructs, LLC
$25.00
Provider : ValuEngine, Inc.
$25.00
Provider : Pechala's Reports
$25.00
Provider : Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.